A randomised, double-blind, active-controlled parallel group study to evaluate theeffect of 52 weeks of once daily treatment of orally inhaled tiotropium Olodaterolfixed dose combination compared with tiotropium on Chronic ObstructivePulmonary Disease (COPD) exacerbation in patients with severe to very severeCOPD. [DYNAGITO]